Filip Bergquist

Also affiliated with University of Gothenburg

MedicineNeuroscienceHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study”.

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study

Neurology and Therapy(2023)10.1007/s40120-023-00533-1

N/A

5.3DataRank · unranked

122 citations

Eric Freire-Álvarez, А. В. Амелин, Angelo Antonini, Bruno Bergmans, Filip Bergquist +17 more

Improved Sleep Correlates with Improved Quality of Life and Motor Symptoms with Foslevodopa/Foscarbidopa

Movement Disorders Clinical Practice(2024)10.1002/mdc3.14018

N/A

0.808DataRank · unranked

19 citations

Maurizio Facheris, Bruno Bergmans, Filip Bergquist, Susan R. Criswell, Jia Jia +7 more